BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 1332849)

  • 1. Growth hormone-releasing hormone is produced by rat Leydig cell in culture and acts as a positive regulator of Leydig cell function.
    Ciampani T; Fabbri A; Isidori A; Dufau ML
    Endocrinology; 1992 Dec; 131(6):2785-92. PubMed ID: 1332849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-mediated actions of growth hormone releasing factor on granulosa cell differentiation.
    Moretti C; Bagnato A; Solan N; Frajese G; Catt KJ
    Endocrinology; 1990 Nov; 127(5):2117-26. PubMed ID: 2171907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin-releasing factor is produced by rat Leydig cells and has a major local antireproductive role in the testis.
    Fabbri A; Tinajero JC; Dufau ML
    Endocrinology; 1990 Sep; 127(3):1541-3. PubMed ID: 2167219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does gonadotropin receptor complex have an amplifying role in cAMP/testosterone production in Leydig cells?
    Browne ES; Bhalla VK
    J Androl; 1991; 12(2):132-9. PubMed ID: 1646778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of corticotropin-releasing factor secretion from Leydig cells by serotonin.
    Tinajero JC; Fabbri A; Dufau ML
    Endocrinology; 1992 Apr; 130(4):1780-8. PubMed ID: 1312425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous and pulsatile infusions of luteinizing hormone have identical effects on steroidogenic capacity and sensitivity of Leydig cells in rats passively immunized against gonadotropin-releasing hormone.
    Gibson-Berry KL; Chase DJ
    Endocrinology; 1990 Jun; 126(6):3107-15. PubMed ID: 1693567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of hCG binding sites and hCG stimulated steroidogenesis in different populations of interstitial cells.
    Bhalla VK; Browne ES; Sohal GS
    Adv Exp Med Biol; 1987; 219():489-513. PubMed ID: 2829579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor alpha inhibits gonadotropin action in cultured porcine Leydig cells: site(s) of action.
    Mauduit C; Hartmann DJ; Chauvin MA; Revol A; Morera AM; Benahmed M
    Endocrinology; 1991 Dec; 129(6):2933-40. PubMed ID: 1659519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mechanism of action of corticotropin releasing factor in rat Leydig cells.
    Ulisse S; Fabbri A; Tinajero JC; Dufau ML
    J Biol Chem; 1990 Feb; 265(4):1964-71. PubMed ID: 2153673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticotropin-releasing factor receptors and actions in rat Leydig cells.
    Ulisse S; Fabbri A; Dufau ML
    J Biol Chem; 1989 Feb; 264(4):2156-63. PubMed ID: 2464587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoactive intestinal peptide receptor regulation of cAMP accumulation and glycogen hydrolysis in the human Ewing's sarcoma cell line WE-68.
    Van Valen F; Jürgens H; Winkelmann W; Keck E
    Cell Signal; 1989; 1(5):435-46. PubMed ID: 2561912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal regulation of androgen biosynthesis by primary cultures of testis cells from neonatal rats.
    Meidan R; Lim P; McAllister JM; Hsueh AJ
    Endocrinology; 1985 Jun; 116(6):2473-82. PubMed ID: 3888612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoactive intestinal peptide effects on GH3 pituitary tumor cells: high affinity binding, affinity labeling, and adenylate cyclase stimulation. Comparison with peptide histidine isoleucine and growth hormone-releasing factor.
    Wood CL; O'Dorisio MS; Vassalo LM; Malarkey WB; O'Dorisio TM
    Regul Pept; 1985 Nov; 12(3):237-48. PubMed ID: 3001842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
    Gespach C; Bawab W; de Cremoux P; Calvo F
    Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ontogenic development of vasoactive intestinal peptide receptors in rat intestinal cells and liver.
    Chastre E; Emami S; Rosselin G; Gespach C
    Endocrinology; 1987 Dec; 121(6):2211-21. PubMed ID: 2824182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the growth hormone-releasing hormone gene and its peptide product in the rat ovary.
    Bagnato A; Moretti C; Ohnishi J; Frajese G; Catt KJ
    Endocrinology; 1992 Mar; 130(3):1097-102. PubMed ID: 1537276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of insulin and insulin-like growth factor I receptors of purified Leydig cells and their role in steroidogenesis in primary culture: a comparative study.
    Lin T; Haskell J; Vinson N; Terracio L
    Endocrinology; 1986 Oct; 119(4):1641-7. PubMed ID: 2944738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The quantification of steroidogenesis-stimulating activity in testicular interstitial fluid by an in vitro bioassay employing adult rat Leydig cells.
    Hedger MP; Robertson DM; de Kretser DM; Risbridger GP
    Endocrinology; 1990 Oct; 127(4):1967-77. PubMed ID: 2169409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of bovine thyrotropin to receptors in rat testis and its interaction with gonadotropins.
    Amir SM; Sullivan RC; Ingbar SH
    Endocrinology; 1978 Jul; 103(1):101-11. PubMed ID: 217636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-2 is a potent inhibitor of Leydig cell steroidogenesis.
    Guo H; Calkins JH; Sigel MM; Lin T
    Endocrinology; 1990 Sep; 127(3):1234-9. PubMed ID: 2167211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.